Company recalls anticoagulant
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.
Related News Articles
Headline
A case study by the AHA's Community Health Improvement network highlights how Renown Health in Reno, Nev., used its community health assessment to address…
Headline
The Common Health Coalition today announced it has extended the deadline to Feb. 3 to apply for the Common Health Challenge Catalyst Award program grant. Each…
Headline
The AHA’s Institute for Diversity and Health Equity’s newly released infographic highlights the importance of leveraging community collaborations to achieve…
Blog
As we commemorate the 39th anniversary of the Martin Luther King Jr. federal holiday, we are reminded of his timeless words: "Of all the forms of inequality,…
Headline
The AHA's Advancing Health podcast recently celebrated the end of 2024 by releasing highlights from some of its most popular episodes of the year. The roundup…
Headline
In this conversation, three experts from Boston Medical Center discuss the development of its Health Equity Accelerator, the partnerships needed to sustain the…